Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

ASHG declares 2015 recipients of annual Award for Excellence in Human Genetics Education

The American Society of Human Genetics (ASHG) has named Robert L. Nussbaum, M.D., chief medical officer of invitae and clinical professor of medicine (volunteer) at the University of California, San Francisco (UCSF); Roderick R. McInnes, CM, M.D., Ph.D., director of the Lady Davis Institute at the Jewish General Hospital and Alva chair in human genetics, Canada Research chair in neurogenetics, and professor of human genetics and biochemistry at McGill University; and Huntington F. Willard, Ph.D., president and director of the Marine Biological Laboratory and professor of human genetics at the University of Chicago; as the 2015 recipients of its annual Award for Excellence in Human Genetics Education.

1 Jul 2015

Pharma Two B reports positive results from P2B001 Phase IIb study for treatment of early stage PD

Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously approved drugs, announced today the successful results of the company's Phase IIb pivotal study of P2B001 for the treatment of early stage Parkinson's Disease (PD).

30 Jun 2015

New UK Parkinson's Excellence Network can transform care for people affected by Parkinson's

The newly launched UK Parkinson's Excellence Network can transform care for those affected by Parkinson's, according to an article in Neurodegenerative Disease Management.

26 Jun 2015

Errors on memory and thinking tests may signal Alzheimer's 18 years before diagnosis

A new study suggests that errors on memory and thinking tests may signal Alzheimer's up to 18 years before the disease can be diagnosed. The research is published in the June 24, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

26 Jun 2015

Potential new class of drugs lessen neurodegeneration in rat model of Parkinson's disease

The first test in a mammalian model of a potential new class of drugs to treat Parkinson's disease shows abatement of neurodegeneration in the brains of test rats and no significant toxicities, University of Alabama at Birmingham and Pfizer Inc. researchers report online in The Journal of Biological Chemistry.

26 Jun 2015

University of Pittsburgh surgeon receives Anthony Cerami Award in Translational Medicine

The Feinstein Institute for Medical Research and Molecular Medicine announced today that the fourth Anthony Cerami Award in Translational Medicine will be conferred to Thomas E. Starzl, MD, PhD, professor of surgery at the University of Pittsburgh School of Medicine. The award is in recognition of his research in organ transplantation and alloengraftment mechanisms.

26 Jun 2015

New 3D cell culture system could facilitate search for therapeutic agents for Parkinson's disease

The progressive loss of neurons in the brain of Parkinson's patients is slow yet inexorable. So far, there are no drugs that can halt this insidious process.

25 Jun 2015

Researchers determine underlying barriers to carrying out effective clinical trials in Parkinson's disease

Despite an urgent need for new medications, clinical trials in Parkinson's disease (PD) have a relatively low rate of success.

25 Jun 2015

WHO prequalifies new male circumcision device to prevent HIV

The ShangRing, a novel medical device for voluntary medical male circumcision, has received prequalification from the World Health Organization (WHO) for use.

25 Jun 2015

OhioHealth Neuroscience Center launched at Riverside Methodist Hospital

On July 6, 2015, OhioHealth will open its doors to the new OhioHealth Neuroscience Center on Riverside Methodist Hospital's campus.

25 Jun 2015

Research shows New Zealand blackcurrants are good for keeping us mentally young and agile

Research has shown that New Zealand blackcurrants are good for keeping us mentally young and agile, a finding that could have potential in managing the mental decline associated with aging populations, or helping people with brain disorders such as Parkinson's disease or depression.

24 Jun 2015

New study aims to raise awareness of Parkinson’s disease, improve quality of life

Raising awareness of Parkinson’s Disease (PD) and improving the quality of life for sufferers is the aim of a new study at Griffith University.

24 Jun 2015

Parkinson's disease may start in the gastrointestinal tract

The chronic neurodegenerative Parkinson's disease affects an increasing number of people. However, scientists still do not know why some people develop Parkinson's disease. Now researchers from Aarhus University and Aarhus University Hospital have taken an important step towards a better understanding of the disease.

24 Jun 2015

Opioid offers pain relief for Parkinson’s patients

Prolonged-release combined oxycodone/naloxone may provide relief for patients with severe pain related to Parkinson’s disease, a double-blind randomised trial shows.

22 Jun 2015

PD linked to increased cancer risk in Asian population

A Taiwanese population-based cohort study reports an increased risk of most cancers in patients with Parkinson’s disease, contrasting with findings in Western populations.

19 Jun 2015

Nonmotor features may predict PD progression

The presence of mild cognitive impairment, orthostatic hypotension, and rapid eye movement sleep behaviour disorder may identify a subset of Parkinson’s disease patients with a poor prognosis, research suggests.

19 Jun 2015

NYU Langone receives $25 million to establish Fresco Institute for PD and movement disorders

NYU Langone Medical Center today announced that the Paolo and Marlene Fresco Foundation (Fresco Foundation) has generously given $25 million to establish the international Marlene and Paolo Fresco Institute for Parkinson's & Movement Disorders.

16 Jun 2015

Research explores screening methods, clinical care for patients with Alzheimer's and all forms of dementia

Every 67 seconds someone is the United States develops Alzheimer's disease or some form of dementia. It's the sixth leading cause of death in the U.S. and it's the only cause of death in the top 10 in America that cannot be prevented, cured or slowed. This month, as the nation observes "Alzheimer's & Brain Awareness Month," James E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country, is at the helm of cutting-edge research, screening methods and clinical care for all forms of dementia and cognitive impairments as well as neurodegenerative diseases like Alzheimer's disease and Parkinson's disease.

16 Jun 2015

Researchers develop hPSC-based system for producing connections between neurons in the brain

Human stem cells can be differentiated to produce other cell types, such as organ cells, skin cells, or brain cells. While organ cells, for example, can function in isolation, brain cells require synapses, or connectors, between cells and between regions of the brain. In a new study published in Restorative Neurology and Neuroscience, researchers report successfully growing multiple brain structures and forming connections between them in vitro, in a single culture vessel, for the first time.

16 Jun 2015

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

BIAL is presenting 11 research posters at the 19th International Congress of Parkinson's Disease and Movement Disorders (June 14–15, San Diego, CA). These evaluate the safety and efficacy of opicapone (BIA 9-1067), a novel once-daily catechol-O-methyltransferase (COMT) inhibitor for use as adjunctive therapy in levodopa-treated Parkinson’s disease patients with end of dose motor fluctuations.

15 Jun 2015

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

ASHG declares 2015 recipients of annual Award for Excellence in Human Genetics Education

Pharma Two B reports positive results from P2B001 Phase IIb study for treatment of early stage PD

New UK Parkinson's Excellence Network can transform care for people affected by Parkinson's

Errors on memory and thinking tests may signal Alzheimer's 18 years before diagnosis

Potential new class of drugs lessen neurodegeneration in rat model of Parkinson's disease

University of Pittsburgh surgeon receives Anthony Cerami Award in Translational Medicine

New 3D cell culture system could facilitate search for therapeutic agents for Parkinson's disease

Researchers determine underlying barriers to carrying out effective clinical trials in Parkinson's disease

WHO prequalifies new male circumcision device to prevent HIV

OhioHealth Neuroscience Center launched at Riverside Methodist Hospital

Research shows New Zealand blackcurrants are good for keeping us mentally young and agile

New study aims to raise awareness of Parkinson’s disease, improve quality of life

Parkinson's disease may start in the gastrointestinal tract

Opioid offers pain relief for Parkinson’s patients

PD linked to increased cancer risk in Asian population

Nonmotor features may predict PD progression

NYU Langone receives $25 million to establish Fresco Institute for PD and movement disorders

Research explores screening methods, clinical care for patients with Alzheimer's and all forms of dementia

Researchers develop hPSC-based system for producing connections between neurons in the brain

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in